Zdrowie i gospodarka · 25/02/2015

FDA Opens Public Comment Period on Racial and Ethnic Health Concerns

The Food and Drug Administration (FDA) is seeking public input on areas of public health concern for racial and ethnic demographic subgroup populations, focusing on disease areas where significant outcome differences may be anticipated, in order to inform additional research by the Office of Minority Health.